N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection.

Gokhale NS, McIntyre ABR, McFadden MJ, Roder AE, Kennedy EM, Gandara JA, Hopcraft SE, Quicke KM, Vazquez C, Willer J, Ilkayeva OR, Law BA, Holley CL, Garcia-Blanco MA, Evans MJ, Suthar MS, Bradrick SS, Mason CE, Horner SM. · 2016

Read N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection. by Gokhale NS, McIntyre ABR, McFadden MJ, Roder AE, Kennedy EM, Gandara JA, Hopcraft SE, Quicke KM, Vazquez C, Willer J, Ilkayeva OR, Law BA, Holley CL, Garcia-Blanco MA, Evans MJ, Suthar MS, Bradrick SS, Mason CE, Horner SM. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5123813.txt.

Introduction

Nandan S. Gokhale and a large team of co-authors studied a chemical mark on viral RNA in Cell Host and Microbe in 2016. The mark, called m6A, is added to RNA letters and read by proteins that can boost or destroy the message. They asked what it does during infection by hepatitis C virus and its relatives.

Removing the enzymes that add the mark increased production of infectious virus, while removing a mark-eraser decreased it. Reader proteins moved to the virus's assembly sites during infection, and blocking one spot of marking on the viral genome raised virus output without changing RNA copying. Mapping the mark across dengue, Zika, yellow fever, and West Nile viruses found shared marked regions, making m6A a common control layer for this virus family.

Catalog record

CREATORGokhale NS, McIntyre ABR, McFadden MJ, Roder AE, Kennedy EM, Gandara JA, Hopcraft SE, Quicke KM, Vazquez C, Willer J, Ilkayeva OR, Law BA, Holley CL, Garcia-Blanco MA, Evans MJ, Suthar MS, Bradrick SS, Mason CE, Horner SM.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5123813

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection By Nandan S. Gokhale, Alexa B.R. McIntyre, Michael J. McFadden, Allison E. Roder, Edward M. Kennedy, Jorge A. Gandara, Sharon E. Hopcraft, Kendra M. Quicke, Christine Vazquez, Jason Willer, Olga R. Ilkayeva, Brittany A. Law Published in: Cell Host & Microbe DOI: 10.1016/j.chom.2016.09.015 ABSTRACT Summary The RNA modification N6-methyladenosine (m6A) post-transcriptionally regulates RNA function. The cellular machinery that controls m6A includes methyltransferases and demethylases that add or remove this modification, as well as m6A-binding YTHDF proteins that promote the translation or degradation of m6A-modified mRNA. We demonstrate that m6A modulates infection by hepatitis C virus (HCV). Depletion of m6A methyltransferases or an m6A demethylase, respectively, increases or decreases infectious HCV particle production. During HCV infection, YTHDF proteins relocalize to lipid droplets, sites of viral assembly, and their depletion increases infectious viral particles. We further mapped m6A sites across the HCV genome and determined that inactivating m6A in one viral genomic region increases viral titer without affecting RNA replication. Additional mapping of m6A on the RNA genomes of other Flaviviridae, including dengue, Zika, yellow fever, and West Nile virus, identifies conserved regions modified by m6A. Altogether, this work identifies m6A as a conserved regulatory mark across Flaviviridae genomes. INTRODUCTION The chemical modification of RNA is an important post-transcriptional regulator of RNA. Of the many known RNA modifications, N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic mRNAs, contributing to RNA structure, localization, and function (Fu et al., 2014, Meyer and Jaffrey, 2014). m6A regulates many biological processes, including stress responses, fertility, stem cell differentiation, circadian rhythms, microRNA (miRNA) biogenesis, and cancer (Li and Mason, 2014, Saletore et al., 2012, Yue et al., 2015, Zhou et al., 2015). However, little is known about its effects on microbial infection. m6A has long been known to be present in the RNA transcripts of viruses with nuclear replication, such as influenza A virus, simian virus 40, Rous sarcoma virus, avian sarcoma virus, and adenovirus (Dimock and Stoltzfus, 1977, Kane and Beemon, 1985, Krug et al., 1976, Lavi and Shatkin, 1975, Sommer et al., 1976). More recently, we and others have shown that m6A serves as a positive regulator of HIV-1, a retrovirus with a nuclear replication step (Kennedy et al., 2016, Lichinchi et al., 2016, Tirumuru et al., 2016). However, a role for m6A in regulating the life cycle of viruses that replicate exclusively in the cytoplasm, such as viruses within the Flaviviridae family, has been unexplored. Flaviviridae, including Zika virus (ZIKV), dengue virus (DENV), West Nile virus (WNV), yellow fever virus (YFV), and hepatitis C virus (HCV), represent both established and emerging pathogens. They contain a positive-sense, single-stranded RNA genome that encodes a viral polyprotein and use similar replication strategies. RNA-based regulation of these viral genomes plays a fundamental role in their infection, such as the liver-specific miRNA miR-122 for HCV replication, RNA structural elements for HCV and DENV replication, and 2′-O methylation of the 5′ cap of WNV RNA for immune evasion and WNV replication (Bidet and Garcia-Blanco, 2014, Hyde et al., 2014, Jopling et al., 2005, Mauger et al., 2015, Pirakitikulr et al., 2016). The cellular machinery that regulates m6A includes proteins that act as writers, erasers, and readers of m6A. The addition of m6A on mRNA, which occurs at the consensus motif DRAmCH (where D = G/A/U, R = G > A, and H = U/C/A), is mediated by a methyltransferase complex containing the methyltransferase-like (METTL) enzymes METTL3 and METTL14 and the cofactors Wilms tumor 1-associated protein (WTAP) and KIAA1429 (Fu et al., 2014, Liu et al., 2014, Meyer and Jaffrey, 2014, Schwartz et al., 2014, Yue et al., 2015). The removal of m6A from mRNA is catalyzed by the demethylases fat mass and obesity-associated protein (FTO) or α-ketoglutarate-dependent dioxygenase AlkB homolog 5 (ALKBH5) (Jia et al., 2011, Zheng et al., 2013). The cytoplasmic YTH-domain family 1 (YTHDF1), YTHDF2, and YTHDF3 proteins bind to m6A through their C-terminal YTH domain. Functionally, YTHDF1 promotes the translation of m6A-modified mRNA, while YTHDF2 targets m6A-modified mRNAs for degradation (Wang et al., 2014, Wang et al., 2015). The function of YTHDF3 is still unknown. The discovery of these proteins and the development of high-throughput m6A-mapping techniques have led to many insights into the function of m6A (Dominissini et al., 2012, Fu et al., 2014, Linder et al., 2015, Meyer et al., 2012). Nonetheless, many aspects of the regulation of specific mRNAs by m6A remain unexplored. Here, we define a role for m6A in regulating the life cycle of HCV. We demonstrate that the m6A methyltransferases negatively regulate the production of infectious HCV particles and that the m6A-binding YTHDF proteins all relocalize to sites of HCV particle production and suppress this stage of viral infection. We map m6A across the HCV RNA genome and show that preventing m6A at one of these regions enhances viral titer by increasing the interaction of the HCV RNA with the HCV Core protein. Finally, we describe viral RNA m6A-epitranscriptomic maps for several other Flaviviridae, including ZIKV, DENV, WNV, and YFV. Altogether, our data reveal that m6A regulates HCV infection and set the stage for the exploration of the function of m6A within the broader Flaviviridae family of viruses. RESULTS The m6A Machinery Regulates HCV Particle Production To determine whether m6A regulates HCV infection, we depleted the m6A methyltransferases METTL3 and METTL14 (METTL3+14) by small interfering RNA (siRNA) in Huh7 liver hepatoma cells and infected these cells with HCV. Immunoblot analysis of cell extracts harvested at 72 hr post-infection (hpi) revealed that METTL3+14 depletion significantly increased the abundance of the HCV NS5A protein, a marker of viral replication, relative to its level in cells treated with non-targeting control siRNA (Figure 1A). Conversely, depletion of the m6A demethylase FTO decreased HCV NS5A levels relative to the control (Figure 1A). Furthermore, we found that the percentage of HCV-positive cells increased after METTL3+14 depletion and decreased after FTO depletion (Figures 1B, 1C, and S1A). This change in HCV-positive cells occurred only after 24 hpi, suggesting that viral entry was unaffected by m6A machinery depletion. Depletion of the m6A machinery did not impair cell viability during infection (Figure S1B). In addition, HCV infection slightly reduced METTL3 protein levels in total cellular extracts, while METTL14 and FTO were unaffected (Figures S1C and S1D). Thus, the m6A methyltransferases negatively regulate HCV infection, while the m6A demethylase positively regulates HCV infection. We next defined the stage of the HCV life cycle regulated by the m6A machinery. Depletion of METTL3+14 significantly increased the production of infectious virus and viral RNA in the supernatant compared to control siRNA at 72 hpi (Figures 1D and 1E). Conversely, depletion of FTO decreased infectious virus and HCV RNA in the supernatant (Figures 1D and 1E) without altering the viral-specific infectivity (Figure S1E). Depletion of ALKBH5 did not affect viral titer or protein levels, indicating that this demethylase does not influence the HCV life cycle (Figure S1F). We next tested whether the altered HCV titer after m6A machinery depletion was due to altered viral RNA replication. In these experiments, we used Huh7.5 CD81 knockout (KO) cells, in which essential HCV entry factor CD81 (Zhang et al., 2004) was deleted by clustered regularly interspaced short palindromic

Read the complete text